Report Detail

Other Global Gene Therapy for Ovarian Cancer Market Size, Status and Forecast 2019-2025

  • RnM3472147
  • |
  • 12 July, 2019
  • |
  • Global
  • |
  • 98 pages
  • |
  • QYResearch
  • |
  • Other

Global Gene Therapy for Ovarian Cancer Market Size, Status and Forecast 2019-2025

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Gene Therapy for Ovarian Cancer Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Intravenous
      • 1.4.3 Intratumoral
      • 1.4.4 Intraperitoneal
    • 1.5 Market by Application
      • 1.5.1 Global Gene Therapy for Ovarian Cancer Market Share by Application (2014-2025)
      • 1.5.2 Ovarian Cancer (unspecified)
      • 1.5.3 Recurrent Ovarian Epithelial Cancer
      • 1.5.4 Platinum-Resistant Ovarian Cancer
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Gene Therapy for Ovarian Cancer Market Size
    • 2.2 Gene Therapy for Ovarian Cancer Growth Trends by Regions
      • 2.2.1 Gene Therapy for Ovarian Cancer Market Size by Regions (2014-2025)
      • 2.2.2 Gene Therapy for Ovarian Cancer Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 Gene Therapy for Ovarian Cancer Market Size by Manufacturers
      • 3.1.1 Global Gene Therapy for Ovarian Cancer Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global Gene Therapy for Ovarian Cancer Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global Gene Therapy for Ovarian Cancer Market Concentration Ratio (CR5 and HHI)
    • 3.2 Gene Therapy for Ovarian Cancer Key Players Head office and Area Served
    • 3.3 Key Players Gene Therapy for Ovarian Cancer Product/Solution/Service
    • 3.4 Date of Enter into Gene Therapy for Ovarian Cancer Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Gene Therapy for Ovarian Cancer Market Size by Type (2014-2019)
    • 4.2 Global Gene Therapy for Ovarian Cancer Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Gene Therapy for Ovarian Cancer Market Size (2014-2019)
    • 5.2 Gene Therapy for Ovarian Cancer Key Players in United States
    • 5.3 United States Gene Therapy for Ovarian Cancer Market Size by Type
    • 5.4 United States Gene Therapy for Ovarian Cancer Market Size by Application

    6 Europe

    • 6.1 Europe Gene Therapy for Ovarian Cancer Market Size (2014-2019)
    • 6.2 Gene Therapy for Ovarian Cancer Key Players in Europe
    • 6.3 Europe Gene Therapy for Ovarian Cancer Market Size by Type
    • 6.4 Europe Gene Therapy for Ovarian Cancer Market Size by Application

    7 China

    • 7.1 China Gene Therapy for Ovarian Cancer Market Size (2014-2019)
    • 7.2 Gene Therapy for Ovarian Cancer Key Players in China
    • 7.3 China Gene Therapy for Ovarian Cancer Market Size by Type
    • 7.4 China Gene Therapy for Ovarian Cancer Market Size by Application

    8 Japan

    • 8.1 Japan Gene Therapy for Ovarian Cancer Market Size (2014-2019)
    • 8.2 Gene Therapy for Ovarian Cancer Key Players in Japan
    • 8.3 Japan Gene Therapy for Ovarian Cancer Market Size by Type
    • 8.4 Japan Gene Therapy for Ovarian Cancer Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Gene Therapy for Ovarian Cancer Market Size (2014-2019)
    • 9.2 Gene Therapy for Ovarian Cancer Key Players in Southeast Asia
    • 9.3 Southeast Asia Gene Therapy for Ovarian Cancer Market Size by Type
    • 9.4 Southeast Asia Gene Therapy for Ovarian Cancer Market Size by Application

    10 India

    • 10.1 India Gene Therapy for Ovarian Cancer Market Size (2014-2019)
    • 10.2 Gene Therapy for Ovarian Cancer Key Players in India
    • 10.3 India Gene Therapy for Ovarian Cancer Market Size by Type
    • 10.4 India Gene Therapy for Ovarian Cancer Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Gene Therapy for Ovarian Cancer Market Size (2014-2019)
    • 11.2 Gene Therapy for Ovarian Cancer Key Players in Central & South America
    • 11.3 Central & South America Gene Therapy for Ovarian Cancer Market Size by Type
    • 11.4 Central & South America Gene Therapy for Ovarian Cancer Market Size by Application

    12 International Players Profiles

    • 12.1 Takara Bio
      • 12.1.1 Takara Bio Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Gene Therapy for Ovarian Cancer Introduction
      • 12.1.4 Takara Bio Revenue in Gene Therapy for Ovarian Cancer Business (2014-2019)
      • 12.1.5 Takara Bio Recent Development
    • 12.2 VBL Therapeutics
      • 12.2.1 VBL Therapeutics Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Gene Therapy for Ovarian Cancer Introduction
      • 12.2.4 VBL Therapeutics Revenue in Gene Therapy for Ovarian Cancer Business (2014-2019)
      • 12.2.5 VBL Therapeutics Recent Development
    • 12.3 CELSION
      • 12.3.1 CELSION Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Gene Therapy for Ovarian Cancer Introduction
      • 12.3.4 CELSION Revenue in Gene Therapy for Ovarian Cancer Business (2014-2019)
      • 12.3.5 CELSION Recent Development
    • 12.4 Targovax
      • 12.4.1 Targovax Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Gene Therapy for Ovarian Cancer Introduction
      • 12.4.4 Targovax Revenue in Gene Therapy for Ovarian Cancer Business (2014-2019)
      • 12.4.5 Targovax Recent Development

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      Ovarian cancer occurs and arises from several types of cells within the ovary, and it has the lowest survival rate of all gynecological cancers. Among many types, epithelial ovarian cancer (EOC) is the most common ovarian cancer, whereas ovarian low malignant potential tumor (OLMPT), germ cell tumor, and stromal ovarian tumor are some of the less common types. It is the seventh most common cancer in women globally and 18th most common cancer overall. The ovarian cancer immunotherapies market has already got some commercially successful chemotherapy products. However, chemotherapy often involves a combination of two or more drugs, given intravenously every 3-4 weeks, and mostly associated with long-lasting side/adverse effects. Various studies have shown that chemotherapy can damage the blood-producing cells of the bone marrow, resulting in blood-related complications.
      Gene therapy is expected to be one of the next big paradigm shift in pharmacology due to the extensive on-going research studies, both at academic and industry level. Gene therapy is one of the most exciting approaches for the treatment of ovarian cancer. Replacement gene therapy is gaining attention as it has the potential to cure ovarian cancer and can be used as a promising option for long-lasting treatment.
      In 2018, the global Gene Therapy for Ovarian Cancer market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global Gene Therapy for Ovarian Cancer status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Gene Therapy for Ovarian Cancer development in United States, Europe and China.

      The key players covered in this study
      Takara Bio
      VBL Therapeutics
      CELSION
      Targovax
      ...

      Market segment by Type, the product can be split into
      Intravenous
      Intratumoral
      Intraperitoneal

      Market segment by Application, split into
      Ovarian Cancer (unspecified)
      Recurrent Ovarian Epithelial Cancer
      Platinum-Resistant Ovarian Cancer

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Gene Therapy for Ovarian Cancer status, future forecast, growth opportunity, key market and key players.
      To present the Gene Therapy for Ovarian Cancer development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Gene Therapy for Ovarian Cancer are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


      Summary:
      Get latest Market Research Reports on Gene Therapy for Ovarian Cancer. Industry analysis & Market Report on Gene Therapy for Ovarian Cancer is a syndicated market report, published as Global Gene Therapy for Ovarian Cancer Market Size, Status and Forecast 2019-2025. It is complete Research Study and Industry Analysis of Gene Therapy for Ovarian Cancer market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.


      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,900.00
      $5,850.00
      $7,800.00
      3,125.01
      4,687.52
      6,250.02
      3,471.71
      5,207.56
      6,943.42
      420,365.40
      630,548.10
      840,730.80
      268,573.11
      402,859.67
      537,146.22
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report